6
Participants
Start Date
June 30, 2008
Primary Completion Date
September 30, 2016
Study Completion Date
September 30, 2016
Guardian® blood-sugar monitoring device
The device has a small catheter that will be inserted subcutaneous tissue of the subject's abdomen or thigh set to continuously monitor glucose throughout the ICU stay for up to 15 days.
The University of Texas Southwestern Medical Center at Dallas, Dallas
University of Texas Health Science Center at Tyler, Tyler
University of Texas Health Science Center at Houston, Houston
University of Texas MD Anderson Cancer Center, Houston
University of Texas Medical Branch at Galveston, Galveston
University of Texas Health Science Center at San Antonio, San Antonio
Collaborators (1)
Medtronic
INDUSTRY
M.D. Anderson Cancer Center
OTHER